FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
Clinical trial NCT00673673 · COMPLETED
Trial details
- NCT number
- NCT00673673
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2013-05-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.